Trial intelligence / Profile preview

Vaginal Microbiota Transplant for Recurrent Bacterial Vaginosis

NCT04046900Phase 2Recruiting

Start
Apr 2021
Primary completion
Jan 2027
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 2 trial of vaginal flora transplant in bacterial vaginosis (BV). Started Apr 2021; status: recruiting.

02

Drugs

vaginal flora transplant
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on NCT04046900.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04046900.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call